Close Menu
About
Updates
Events
Resources
Press Room
Join ACT-AD
Search
Search
Close Search Modal
ACT-AD
About
Updates
Events
Resources
Press Room
Join ACT-AD
Mobile Menu
Search
Home
News & Updates
News & Updates
FDA Grants Accelerated Approval for Alzheimer’s Drug
Update
June 7, 2021
Uncategorized
Study: Impact of International Reference Pricing on Alzheimer’s Research and Development
Update
April 22, 2021
Uncategorized
Sponsor Spotlight: Avanir’s Sanjay Dubé, M.D.
Update
March 3, 2021
Sponsor Spotlight
13th Annual FDA/ACT-AD Allies Meeting Recap
Update
February 17, 2021
Uncategorized
ACT-AD Member Spotlight: BrightFocus Foundation
Update
November 25, 2019
Updates
ACT-AD at the 11th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Update
October 31, 2018
Event Recap
ACT-AD Letter on FDA Early Alzheimer’s Disease Guidance
Update
June 15, 2018
FDA
Researchers Reverse Alzheimer’s Disease in Mouse Models
Update
February 10, 2018
Uncategorized
Experimental Drug Could Be Viable Treatment for Alzheimer’s Disease
Update
January 19, 2018
Uncategorized
Canola Oil May Play a Role in Worsening of Alzheimer’s Disease Symptoms
Update
December 28, 2017
Uncategorized
1
2
3
4
5
6
7
8
Next »